EE200200670A - S-metüüldihüdroziprasidoon psühhiaatriliste ja silmahaiguste raviks - Google Patents

S-metüüldihüdroziprasidoon psühhiaatriliste ja silmahaiguste raviks

Info

Publication number: EE200200670A
Authority: EE; Estonia
Prior art keywords: methyldihydroziprasidone; psychiatric; treatment; ocular disorders; ocular
Prior art date: 2000-06-02

Application number

EEP200200670A

Other languages

English (en)

Estonian (et)

Inventor

Aggarwal Prakash Chandra

Annette Smolarek Teresa

Original Assignee

Pfizer Products Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-06-02

Filing date

2001-05-28

Publication date

2004-08-16

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26903852&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EE200200670(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2001-05-28 Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.

2004-08-16 Publication of EE200200670A publication Critical patent/EE200200670A/xx

Links

NHUDBVVEHOSVCD-UHFFFAOYSA-N 6-chloro-5-[2-[4-(2-methylsulfanylbenzenecarboximidoyl)piperazin-1-yl]ethyl]-1,3-dihydroindol-2-one Chemical compound CSC1=CC=CC=C1C(=N)N1CCN(CCC=2C(=CC=3NC(=O)CC=3C=2)Cl)CC1 NHUDBVVEHOSVCD-UHFFFAOYSA-N 0.000 title 1
208000022873 Ocular disease Diseases 0.000 title 1
208000020016 psychiatric disease Diseases 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Epidemiology (AREA)
Ophthalmology & Optometry (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Emergency Medicine (AREA)
Heart & Thoracic Surgery (AREA)
Vascular Medicine (AREA)
Psychology (AREA)
Anesthesiology (AREA)
Cardiology (AREA)
Hospice & Palliative Care (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Indole Compounds (AREA)
Hydrogenated Pyridines (AREA)
Medicinal Preparation (AREA)
Plural Heterocyclic Compounds (AREA)

EEP200200670A 2000-06-02 2001-05-28 S-metüüldihüdroziprasidoon psühhiaatriliste ja silmahaiguste raviks EE200200670A (et)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US20913600P	2000-06-02	2000-06-02
US21217200P	2000-06-16	2000-06-16
PCT/IB2001/000933 WO2001091756A2 (fr)	2000-06-02	2001-05-28	S-methyl-dihydro-ziprasidone utilise dans le traitement des troubles psychiatriques et oculaires

Publications (1)

Publication Number	Publication Date
EE200200670A true EE200200670A (et)	2004-08-16

Family

ID=26903852

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EEP200200670A EE200200670A (et)	2000-06-02	2001-05-28	S-metüüldihüdroziprasidoon psühhiaatriliste ja silmahaiguste raviks

Country Status (44)

Country	Link
US (1)	US20060287336A1 (fr)
EP (3)	EP1286672B1 (fr)
JP (2)	JP2003534381A (fr)
KR (1)	KR20030007824A (fr)
CN (1)	CN1431901A (fr)
AP (2)	AP1831A (fr)
AR (1)	AR028937A1 (fr)
AT (3)	ATE343387T1 (fr)
AU (1)	AU2001258690A1 (fr)
BG (1)	BG107267A (fr)
BR (1)	BR0111271A (fr)
CA (1)	CA2410618A1 (fr)
CY (1)	CY1105992T1 (fr)
CZ (1)	CZ20023860A3 (fr)
DE (3)	DE60124791T2 (fr)
DK (1)	DK1468686T3 (fr)
DO (1)	DOP2001000181A (fr)
EA (1)	EA007068B1 (fr)
EC (1)	ECSP024369A (fr)
EE (1)	EE200200670A (fr)
ES (1)	ES2277170T3 (fr)
GE (1)	GEP20053512B (fr)
HN (1)	HN2001000119A (fr)
HR (1)	HRP20020953A2 (fr)
HU (1)	HUP0301747A2 (fr)
IL (2)	IL152782A0 (fr)
IS (1)	IS6619A (fr)
MA (1)	MA26908A1 (fr)
MX (1)	MXPA02011862A (fr)
NO (1)	NO325077B1 (fr)
NZ (1)	NZ551012A (fr)
OA (1)	OA12267A (fr)
PA (1)	PA8518301A1 (fr)
PE (1)	PE20011329A1 (fr)
PL (1)	PL365576A1 (fr)
PT (2)	PT1698338E (fr)
SI (1)	SI1468686T1 (fr)
SK (1)	SK16622002A3 (fr)
SV (1)	SV2002000473A (fr)
UA (1)	UA79425C2 (fr)
UY (1)	UY26742A1 (fr)
WO (1)	WO2001091756A2 (fr)
YU (1)	YU90702A (fr)
ZA (1)	ZA200209665B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7419493B2 (en)	2002-12-13	2008-09-02	Regents Of The University Of Minnesota	Scleral depressor
EP1628973A2 (fr)	2003-10-24	2006-03-01	Teva Pharmaceutical Industries Ltd.	Procedes de preparation de ziprasidone
ES2250001B1 (es) *	2004-09-29	2007-06-01	Medichem, S.A.	Proceso para la purificacion de ziprasidona.
JP2012174228A (ja) *	2011-02-24	2012-09-10	Kyocera Corp	プログラム保護装置および通信装置
WO2014078568A1 (fr)	2012-11-14	2014-05-22	The Johns Hopkins University	Méthodes et compositions pour le traitement de la schizophrénie
US9981041B2 (en) *	2016-08-23	2018-05-29	Ira Jason Salzman	Ophthalmic lubricating spray

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TW491847B (en) *	1996-05-07	2002-06-21	Pfizer	Mesylate dihydrate salts of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)-ethyl)-6-chloro-1,3-dihydro-2h-indol-2-one
CA2252895C (fr) *	1996-05-07	2002-08-20	Pfizer Inc.	Trihydrate du sel mesylate de 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-2(1h)-indol-2-one (=ziprasidone), sa preparation et son utilisation en tant qu'antagoniste du recepteur dopaminergique d2
ATE247963T1 (de) *	1998-05-26	2003-09-15	Pfizer Prod Inc	Medikament zur behandlung von glaukoma und ischämischer retinopathie
AU4062900A (en) *	1999-04-06	2000-10-23	Sepracor, Inc.	Methods and compositions for the treatment of neuroleptic and related disorders using ziprasidone metabolites

2001
- 2001-05-28 CA CA002410618A patent/CA2410618A1/fr not_active Abandoned
- 2001-05-28 AT AT01932011T patent/ATE343387T1/de not_active IP Right Cessation
- 2001-05-28 YU YU90702A patent/YU90702A/sh unknown
- 2001-05-28 AT AT04013380T patent/ATE345818T1/de not_active IP Right Cessation
- 2001-05-28 JP JP2001587771A patent/JP2003534381A/ja not_active Withdrawn
- 2001-05-28 ES ES04013380T patent/ES2277170T3/es not_active Expired - Lifetime
- 2001-05-28 IL IL15278201A patent/IL152782A0/xx active IP Right Grant
- 2001-05-28 EP EP01932011A patent/EP1286672B1/fr not_active Expired - Lifetime
- 2001-05-28 BR BR0111271-6A patent/BR0111271A/pt not_active Application Discontinuation
- 2001-05-28 DE DE60124791T patent/DE60124791T2/de not_active Expired - Fee Related
- 2001-05-28 EP EP04013380A patent/EP1468686B1/fr not_active Expired - Lifetime
- 2001-05-28 SI SI200130681T patent/SI1468686T1/sl unknown
- 2001-05-28 CZ CZ20023860A patent/CZ20023860A3/cs unknown
- 2001-05-28 PL PL01365576A patent/PL365576A1/xx unknown
- 2001-05-28 HR HR20020953A patent/HRP20020953A2/hr not_active Application Discontinuation
- 2001-05-28 WO PCT/IB2001/000933 patent/WO2001091756A2/fr not_active Ceased
- 2001-05-28 NZ NZ551012A patent/NZ551012A/en unknown
- 2001-05-28 AT AT06116051T patent/ATE391507T1/de not_active IP Right Cessation
- 2001-05-28 EA EA200201168A patent/EA007068B1/ru not_active IP Right Cessation
- 2001-05-28 SK SK1662-2002A patent/SK16622002A3/sk not_active Application Discontinuation
- 2001-05-28 GE GE4972A patent/GEP20053512B/en unknown
- 2001-05-28 KR KR1020027016364A patent/KR20030007824A/ko not_active Ceased
- 2001-05-28 DK DK04013380T patent/DK1468686T3/da active
- 2001-05-28 PT PT06116051T patent/PT1698338E/pt unknown
- 2001-05-28 AU AU2001258690A patent/AU2001258690A1/en not_active Abandoned
- 2001-05-28 DE DE60124093T patent/DE60124093D1/de not_active Expired - Lifetime
- 2001-05-28 MX MXPA02011862A patent/MXPA02011862A/es active IP Right Grant
- 2001-05-28 OA OA1200200349A patent/OA12267A/en unknown
- 2001-05-28 PT PT04013380T patent/PT1468686E/pt unknown
- 2001-05-28 CN CN01810620A patent/CN1431901A/zh active Pending
- 2001-05-28 HU HU0301747A patent/HUP0301747A2/hu unknown
- 2001-05-28 DE DE60133596T patent/DE60133596D1/de not_active Expired - Lifetime
- 2001-05-28 UA UA2002119557A patent/UA79425C2/uk unknown
- 2001-05-28 EE EEP200200670A patent/EE200200670A/xx unknown
- 2001-05-28 EP EP06116051A patent/EP1698338B1/fr not_active Expired - Lifetime
- 2001-05-31 HN HN2001000119A patent/HN2001000119A/es unknown
- 2001-05-31 DO DO2001000181A patent/DOP2001000181A/es unknown
- 2001-05-31 AP APAP/P/2001/002180A patent/AP1831A/en active
- 2001-05-31 AP AP2005003272A patent/AP1747A/xx active
- 2001-05-31 PE PE2001000504A patent/PE20011329A1/es not_active Application Discontinuation
- 2001-05-31 UY UY26742A patent/UY26742A1/es not_active Application Discontinuation
- 2001-06-01 AR ARP010102641A patent/AR028937A1/es unknown
- 2001-06-01 SV SV2001000473A patent/SV2002000473A/es not_active Application Discontinuation
- 2001-06-01 PA PA20018518301A patent/PA8518301A1/es unknown
- 2001-06-04 US US09/873,973 patent/US20060287336A1/en not_active Abandoned
2002
- 2002-11-11 IL IL152782A patent/IL152782A/en not_active IP Right Cessation
- 2002-11-12 BG BG107267A patent/BG107267A/bg unknown
- 2002-11-14 IS IS6619A patent/IS6619A/is unknown
- 2002-11-28 ZA ZA200209665A patent/ZA200209665B/en unknown
- 2002-11-29 MA MA26927A patent/MA26908A1/fr unknown
- 2002-11-29 NO NO20025760A patent/NO325077B1/no unknown
- 2002-11-29 EC EC2002004369A patent/ECSP024369A/es unknown
2007
- 2007-02-08 CY CY20071100161T patent/CY1105992T1/el unknown
- 2007-11-14 JP JP2007296039A patent/JP2008056700A/ja not_active Withdrawn

Also Published As

Publication number	Publication date
AU2001258690A1 (en)	2001-12-11
EP1286672A2 (fr)	2003-03-05
ECSP024369A (es)	2003-02-06
AP1747A (en)	2007-05-31
EA200201168A1 (ru)	2003-06-26
SI1468686T1 (sl)	2007-04-30
DE60124791T2 (de)	2007-09-13
WO2001091756A2 (fr)	2001-12-06
JP2008056700A (ja)	2008-03-13
PT1698338E (pt)	2008-06-03
UA79425C2 (en)	2007-06-25
MA26908A1 (fr)	2004-12-20
DE60124093D1 (de)	2006-12-07
ATE343387T1 (de)	2006-11-15
BR0111271A (pt)	2003-06-10
DE60124791D1 (de)	2007-01-04
EP1468686A2 (fr)	2004-10-20
DOP2001000181A (es)	2002-04-15
HN2001000119A (es)	2001-09-11
GEP20053512B (en)	2005-05-10
NO20025760D0 (no)	2002-11-29
IL152782A (en)	2007-10-31
DK1468686T3 (da)	2007-03-12
US20060287336A1 (en)	2006-12-21
ATE391507T1 (de)	2008-04-15
CA2410618A1 (fr)	2001-12-06
UY26742A1 (es)	2001-12-28
CN1431901A (zh)	2003-07-23
NO325077B1 (no)	2008-01-28
WO2001091756A3 (fr)	2002-09-26
DE60133596D1 (de)	2008-05-21
CY1105992T1 (el)	2011-04-06
EP1698338B1 (fr)	2008-04-09
JP2003534381A (ja)	2003-11-18
EP1698338A3 (fr)	2006-09-20
SK16622002A3 (sk)	2004-07-07
MXPA02011862A (es)	2003-04-10
HUP0301747A2 (hu)	2003-09-29
EA007068B1 (ru)	2006-06-30
AP2005003272A0 (en)	2005-03-31
PT1468686E (pt)	2007-01-31
PE20011329A1 (es)	2002-01-15
PA8518301A1 (es)	2002-09-17
SV2002000473A (es)	2002-10-24
EP1468686B1 (fr)	2006-11-22
EP1698338A2 (fr)	2006-09-06
IL152782A0 (en)	2003-06-24
AP1831A (en)	2008-02-26
ATE345818T1 (de)	2006-12-15
AR028937A1 (es)	2003-05-28
ES2277170T3 (es)	2007-07-01
BG107267A (bg)	2003-06-30
YU90702A (sh)	2005-11-28
EP1468686A3 (fr)	2004-12-01
NO20025760L (no)	2003-01-15
PL365576A1 (en)	2005-01-10
EP1286672B1 (fr)	2006-10-25
ZA200209665B (en)	2003-11-28
HRP20020953A2 (en)	2005-02-28
NZ551012A (en)	2008-04-30
CZ20023860A3 (cs)	2004-01-14
IS6619A (is)	2002-11-14
KR20030007824A (ko)	2003-01-23
OA12267A (en)	2004-01-20

Publication	Publication Date	Title
NO20026263L (no)	2002-12-27	Sulfonyl-pyrrolidin-derivater anvendelige for behandling av neurologiske forstyrrelser
DK1343773T3 (da)	2007-02-05	Thiazolderivater til behandling af PPAR-beslægtede forstyrrelser
NO993051L (no)	1999-12-23	Intranasale formuleringer for behandling av seksuelle forstyrrelser
DK1047428T3 (da)	2007-10-08	Anvendelse af morpholinol til behandlingen af seksualforstyrrelser
GB0007193D0 (en)	2000-05-17	Treatment of movrmrnt disorders
NO20041386L (no)	2004-05-11	Kombinasjoner for bahandling av immunoinflammatoriske forstyrrelser
NO20032636D0 (no)	2003-06-11	3-indolinderivater som er nyttige i behandlingen av psykiatriske og nevrologiske forstyrrelser
IL155589A0 (en)	2003-11-23	Novel amidoalkyl-piperidine and amidoalkyl-piperazine derivatives useful for the treatment of nervous system disorders
NO20024775D0 (no)	2002-10-03	Hydroksyfenyl-piperidin-4-yliden-metyl-benzamidderivater til behandling av smerte
NO20033803D0 (no)	2003-08-26	Karbamat for behandling av bevegelseslidelser
NO20034123L (no)	2003-09-16	Fremgangsmåte for behandling av brennstoff
EE200200632A (et)	2004-04-15	Glükokortikoidravimeid sisaldavad preparaadid bronhopulmonaalsete haiguste raviks
ID27214A (id)	2001-03-08	Triazolopiridina untuk pengobatan gangguan trombosis
NO20026219L (no)	2003-02-17	Forbindelser for behandling av svekket fundisk relaksasjon
NO20024777L (no)	2002-12-03	Kinolinyl-piperidin-4-yliden-metyl-benzamid derivater til behandling av smerte
NO20024776L (no)	2002-12-03	Hydroksyfenyl-piperazinyl-metyl-benzamid derivater til behandling av smerte
DK1309322T3 (da)	2006-10-23	Anvendelse af 3-benzoylphenyleddikesyrederivater til behandling af retinale lidelser
NO20023803L (no)	2002-10-09	Anvendelse av mirtazapin for behandling av sövnforstyrrelser
EE200200670A (et)	2004-08-16	S-metüüldihüdroziprasidoon psühhiaatriliste ja silmahaiguste raviks
NO20032156D0 (no)	2003-05-13	Behandling av angstforstyrrelser
AR026062A1 (es)	2002-12-26	Tratamiento de desordenes oculares
PT1268482E (pt)	2004-01-30	Piranoindois para o tratamento de glaucoma
ATE230741T1 (de)	2003-01-15	3-tetrahydropyridin-4-yl-indole zur behandlung von psychotischen störungen
NO20030717L (no)	2003-02-14	Forbindelser for behandling av avhengighetsforstyrrelser
NO20012612D0 (no)	2001-05-28	Isonipecotamider for behandling av integren-formidlede lidelser